Organ-on-a-chip (OOC) technology aims to more accurately reproduce human physiology in vitro, addressing the limitations of current approaches. This field is advancing rapidly. Image Credit: CN Bio ...
For those considering adding Organ-on-a-chip (OOC) technology into the workflow, it may be unclear where to start. Firstly, using a commercially available solution, such as CN Bio's PhysioMimix ®, ...
Ottawa, April 22, 2025 (GLOBE NEWSWIRE) -- The global organ-on-a-chip market size was valued at USD 159.48 billion in 2024 and is predicted to hit around USD 3242.34 billion by 2034, a study published ...
The current drug discovery process is inefficient, with a significant number of drugs halting clinical trials, pending more investigational work to understand causality, or failing due to unforeseen ...
SARASOTA, Fla., June 10, 2025 /PRNewswire/ -- World Precision Instruments (WPI), the global leader in transepithelial electrical resistance (TEER) technology, in collaboration with SynVivo, a leader ...
CN Bio, announced the establishment of a strategic partnership with Pharmaron. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix ® technology across existing applications and ...
Researchers at Tampere University have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback